Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LNG-IUS vs LNG-IUS plus oral contraceptive for adenomyosis
NCT02556411Unknown
- Sponsor
- Università degli Studi di Cagliari
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of avatrombopag and ethinyl estradiol in adenomyosis and chronic pelvic pain (CPP), sponsored by Università degli Studi di Cagliari. Primary endpoint: Visual Analogue Scale for Pelvic Pain at 45 days. Status: unknown.
02
Drugs
avatrombopagethinyl estradiol
03
Conditions
adenomyosischronic pelvic pain (CPP)
Beyond the preview
Go deeper on NCT02556411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02556411.